CHEBI:61058 - α-methyl-L-dopa

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-methyl-L-dopa
ChEBI ID CHEBI:61058
ChEBI ASCII Name alpha-methyl-L-dopa
Definition A derivative of L-tyrosine having a methyl group at the α-position and an additional hydroxy group at the 3-position on the phenyl ring.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Save molfile Download Molfile
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C10H13NO4
Net Charge 0
Average Mass 211.21450
Monoisotopic Mass 211.084
InChI InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1
InChIKey CJCSPKMFHVPWAR-JTQLQIEISA-N
SMILES C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O
Roles Classification
Chemical Role(s): Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): sympatholytic agent
Any compound which inhibits the postganglionic functioning of the sympathetic nervous system (SNS).
hapten
Any substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
alpha-adrenergic agonist
An agent that selectively binds to and activates alpha-adrenergic receptors.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via L-alpha-amino acid )
Application(s): sympatholytic agent
Any compound which inhibits the postganglionic functioning of the sympathetic nervous system (SNS).
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
alpha-adrenergic agonist
An agent that selectively binds to and activates alpha-adrenergic receptors.
peripheral nervous system drug
A drug that acts principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing α-methyl-L-dopa (CHEBI:61058) has role α-adrenergic agonist (CHEBI:35569)
α-methyl-L-dopa (CHEBI:61058) has role antihypertensive agent (CHEBI:35674)
α-methyl-L-dopa (CHEBI:61058) has role hapten (CHEBI:59174)
α-methyl-L-dopa (CHEBI:61058) has role peripheral nervous system drug (CHEBI:49110)
α-methyl-L-dopa (CHEBI:61058) has role sympatholytic agent (CHEBI:66991)
α-methyl-L-dopa (CHEBI:61058) is a L-tyrosine derivative (CHEBI:27177)
α-methyl-L-dopa (CHEBI:61058) is a non-proteinogenic L-α-amino acid (CHEBI:83822)
IUPAC Name
3-hydroxy-α-methyl-L-tyrosine
INNs Sources
methyldopa KEGG DRUG
methyldopum ChemIDplus
metildopa ChemIDplus
Synonyms Sources
(S)-(-)-alpha-Methyldopa ChemIDplus
3-Hydroxy-alpha-methyl-L-tyrosine ChemIDplus
Alpha medopa DrugBank
alpha-Methyl dopa ChemIDplus
alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine ChemIDplus
alpha-Methyl-L-3,4-dihydroxyphenylalanine ChemIDplus
alpha-Methyldihydroxyphenylalanine ChemIDplus
alpha-Methyldopa ChemIDplus
Alphamethyldopa DrugBank
AMD DrugBank
L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine ChemIDplus
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine ChemIDplus
L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine ChemIDplus
L-(alpha-Md) ChemIDplus
L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid ChemIDplus
l-3-(3,4-Dihydroxyphenyl)-2-methylalanine ChemIDplus
L-alpha-Methyl-3,4-dihydroxyphenylalanine ChemIDplus
L-alpha-Methyldopa ChemIDplus
L-Methyl Dopa DrugBank
levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine ChemIDplus
Methyl-L-dopa ChemIDplus
Methyldopa KEGG COMPOUND
Methyldopa anhydrous DrugBank
Database Links Databases
C07194 KEGG COMPOUND
D08205 KEGG DRUG
DB00968 DrugBank
HMDB11754 HMDB
LSM-5596 LINCS
Methyldopa Wikipedia
View more database links
Registry Numbers Types Sources
2807721 Reaxys Registry Number Reaxys
555-30-6 CAS Registry Number KEGG COMPOUND
555-30-6 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
10576686 PubMed citation Europe PMC
11901210 PubMed citation Europe PMC
8301021 PubMed citation Europe PMC
Last Modified
25 February 2016
General Comment
2011-01-19 Primary clinical use is as an antihypertensive agent.